Key stats
Market capitalization
104.11MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.55USD
About VolitionRX Limited
ISIN
US9286611077
Sector
Health Technology
Industry
Medical Specialties
Website
volition.com
CEO
Cameron John Reynolds
Headquarters
Henderson
Employees
104
Founded
1998
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.
Volition RX - Positive News required to escape the bearcountryTo shorten things and to keep it simple: According to fibunacci should the stock stabilise at around 3.7$ and higher to keep above the 61.8 retracement.
If the company will publish some good news soon, it could be the signal for an entry.
Entryprice above 3.69$
$VNRX on watchlist for breakout VolitionRX Ltd. is a multi-national life sciences company. It engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluid. The company was
$VNRX Prepping For A Breakout$VNRX has popped on our radar. $VNRX is trading above its 20, 50, and 200 day moving averages. A breakout to new highs above $3.63 sets $VNRX up for a nice move.
Yesterday, the company put out some news.
AUSTIN, Texas, July 18, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Voliti
Bad fundamentals good technicals for VNRXDespite reported second quarter loss of $2.9 million that did not meet Wall street expectations, VNRX (VolitionRX) might look quite bullish in a distant future. Three weeks ago there was a bullish engulfing at the bottom of a enormous rectangle which should imply some bullish momentum. This is why w
See all ideas
Income Statement
Balance Sheet
Cash Flow
Earnings
Next:—
0
Revenue
0